What is the recommended treatment for H pylori (Helicobacter pylori) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

H. pylori Treatment Recommendations

Bismuth quadruple therapy (PPI + bismuth + tetracycline + metronidazole) for 14 days is the recommended first-line treatment for H. pylori infection in regions with high clarithromycin resistance (>15-20%). 1

First-Line Treatment Options

Treatment selection should be based on regional antibiotic resistance patterns:

  1. High clarithromycin resistance regions (>15-20%):

    • Bismuth quadruple therapy: PPI + bismuth + tetracycline + metronidazole for 14 days (85% eradication rate) 1
    • Alternative: Concomitant non-bismuth quadruple therapy: PPI + clarithromycin + amoxicillin + metronidazole for 14 days (80% eradication rate) 1
  2. Low clarithromycin resistance regions (<15-20%):

    • Standard triple therapy: PPI + amoxicillin + clarithromycin for 14 days (85% eradication rate) 1

Specific Dosing Regimens

For H. pylori eradication in adults, the FDA-approved regimens include 2:

  • Triple therapy: 1 gram amoxicillin, 500 mg clarithromycin, and 30 mg lansoprazole, all given twice daily for 14 days
  • Dual therapy: 1 gram amoxicillin and 30 mg lansoprazole, each given three times daily for 14 days

Important administration note: To minimize gastrointestinal intolerance, medications should be taken at the start of a meal 2

Second-Line Treatment Options

After failure of first-line therapy, consider:

  • Bismuth quadruple therapy (if not used initially) 1
  • Levofloxacin-based triple therapy (PPI + amoxicillin + levofloxacin) 1
  • For refractory cases with two failed therapies: rifabutin-based triple therapy or high-dose dual therapy 1

Antibiotic Resistance Testing

  • After two failed therapies with confirmed patient adherence, H. pylori susceptibility testing should guide subsequent regimen selection 1
  • A thorough review of the patient's antibiotic exposure history is essential before selecting a treatment regimen 1

Treatment Duration

All H. pylori eradication regimens should be given for 14 days to improve eradication success rates 1, 3. Extending treatment from 7 to 14 days improves eradication success by approximately 5% 1.

Post-Treatment Follow-Up

  • Wait at least 4 weeks after completing antibiotic therapy before testing for H. pylori eradication 1
  • Urea Breath Test (UBT) is the gold standard non-invasive test (sensitivity 95%, specificity 90%) 1
  • Monoclonal stool antigen test is an acceptable alternative with equivalent accuracy 1

Special Considerations

Renal Impairment

Patients with impaired renal function may require dose adjustments:

  • GFR 10-30 mL/min: 500 mg or 250 mg amoxicillin every 12 hours 2
  • GFR <10 mL/min: 500 mg or 250 mg amoxicillin every 24 hours 2

Common Pitfalls to Avoid

  1. Inadequate treatment duration: 14-day regimens are now strongly recommended over 7-day treatments 1, 3
  2. Ignoring local resistance patterns: Treatment selection should be based on regional antibiotic resistance 1
  3. Poor medication timing: PPIs should be taken 30 minutes prior to eating or drinking on an empty stomach 1
  4. Concomitant antacid use: Avoid using H2 receptor antagonists during treatment 1
  5. Testing too soon after treatment: Wait at least 4 weeks after completing therapy before testing for eradication 1

Dietary and Lifestyle Recommendations

  • Diet low in acidic, spicy, and fatty foods
  • Regular consumption of fruits and vegetables rich in vitamin C
  • Eating smaller, more frequent meals
  • Avoiding eating within 3 hours of bedtime
  • Staying hydrated throughout the day 1

The treatment landscape for H. pylori has evolved due to increasing antibiotic resistance, making quadruple therapies increasingly important as first-line options 3, 4.

References

Guideline

H. pylori Gastritis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.